NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation
Authors:
- Madhavi D. SenagolageMSMadhavi D. Senagolage
- Hunter Z. BlaylockHBHunter Z. Blaylock
- Saira KhanSKSaira Khan
- Sarah J. SkuliSSSarah J. Skuli
- Martin P. CarrollMCMartin P. Carroll
- Megan E. McNerneyMMMegan E. McNerney
Open Access
- 19 May 2025
- journal article
- Published by Elsevier in Blood Neoplasia
- Vol. 2 (3)
Abstract
No abstract availableKeywords
Funding Information
- University of Pennsylvania (SCR_010035)
- Cancer Research Foundation
- Pediatric Cancer Research Foundation
- Leukemia and Lymphoma Society
- National Institutes of Health
- National Heart, Lung, and Blood Institute (F32 HL156600, R01HL142782, R01HL166184)
- University of Chicago (SCR_019196, SCR_017760)
- National Cancer Institute (R01CA231880, T32CA009594)
This publication has 57 references indexed in Scilit:
- Necrostatin-1 reverts shikonin-induced necroptosis to apoptosisApoptosis, 2009
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyThe Lancet Oncology, 2009
- Toxicity Testing using Hematopoietic Stem Cell AssaysRegenerative Medicine, 2007
- Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-BBlood, 2006
- FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.2003
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesBlood, 2003
- Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agentsToxicology in Vitro, 2003
- Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: A reconsideration of the specificity of the annexin V/propidium iodide assayCytometry, 2001
- Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients.1999
- Gene deletion: a new target for cancer chemotherapyThe Lancet, 1993